InvestorsHub Logo
Followers 113
Posts 11900
Boards Moderated 0
Alias Born 07/10/2014

Re: hyperopia post# 240944

Saturday, 08/24/2019 11:41:08 AM

Saturday, August 24, 2019 11:41:08 AM

Post# of 715617
Did you guys notice, the Acting FDA Commish did not mention anything about the phony helmet. He knows it is a sham. Otherwise he would have touched upon the devices. He decided the already approved helmet doesn't deserve to be mentioned. NVCR didn't even strike in his mind while he used so many different words to express his need for a viable gbm therapy. He gave all the clue mentioning immunotherapy. Which immunotherapy survived todate at Phase 3 clinical trial level? The shorts are clueless here. Glad smart LP is taking them blindfolded to a place of no return.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News